Teva Defends Mifepristone Antitrust Case Against Corcept

By Dan McKay · November 15, 2024, 3:55 PM EST

Teva Pharmaceuticals has asked a California federal judge to reject a bid to dismiss its lawsuit against the maker of a brand-name drug used to treat a rare cortisol disorder, contending...

To view the full article, register now.

Documents

Case Information

Case Title

Teva Pharmaceuticals USA, Inc. v. Corcept Therapeutics, Inc. et al

Case Number

5:24-cv-03567

Court

California Northern

Nature of Suit

Anti-Trust

Date Filed

June 13, 2024